Paid Clinical Trials in Marrero, LA
As of June 2026, 55 paid clinical trials are recruiting in Marrero, Louisiana. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Marrero offers studies at sites including West Jefferson Medical Center for conditions such as Alzheimer Disease, Alzheimers Disease, Crohn's Disease, Eosinophilic Esophagitis. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Marrero
Trials by drug in Marrero
Filter results
55 clinical trials
↓ Download CSVDReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Galleri® in the Medicare Population.
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Contraceptive Efficacy Study of Ovaprene
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
About research studies in Marrero
Marrero has approximately 55 recruiting research studies across a wide range of therapeutic areas. Louisiana hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Marrero
Researchers run research studies in Marrero, LA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| West Jefferson Medical Center | Ovarian Carcinoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 13 |
| Tandem Clinical Research | Liver Fibrosis, Ascites Hepatic, Bowel; Stricture | 11 |
| Tandem Clinical Research - Marrero | Atherosclerotic Cardiovascular Disease, Obesity, Overweight | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Local Institution - 1114 | Psychosis Associated With Alzheimer's Disease | 2 |
| Tandem Clinical Research GI, LLC | Eosinophilic Esophagitis, Metabolic Dysfunction-associated Steatohepatitis | 2 |
| Tandem Clinical Research, LLC | Alzheimers Disease | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
| Aligos Investigational Site | Chronic Hepatitis B Infection | 1 |
| Altimmune Clinical Study Site | Alcohol Liver Disease | 1 |
| Care Access-Marrero | Breast Cancer, Breast Cancer Metastatic, Breast Neoplasm | 1 |
| Dr. Falk Investigational Site | Eosinophilic Esophagitis | 1 |
| Drs Same Day Surg Ctr | Lumbar Spinal Stenosis | 1 |
| GSK Investigational Site | Liver Diseases, Alcoholic | 1 |
| InclusivCare - Marrero | Obesity | 1 |
| Local Institution - 0011 | Agitation, Alzheimer Disease | 1 |
| Local Institution - 1655 | Alzheimer Disease | 1 |
| Marrero | Endometriosis, Uterine Fibroids | 1 |
| Mirador Therapeutics Selected Site | Crohn's Disease, Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC) | 1 |
| Neurocrine Clinical Site | Major Depressive Disorder | 1 |
| Ochsner Health Westbank | Cancer | 1 |
| Praetorian Pharmaceutical Research | Vulvovaginal Candidiases, Vulvovaginal Candidiasis (VVC), Vulvovaginal Candidiasis, Genital | 1 |
| Praetorian Pharmaceutical Research, LLC | Contraception | 1 |
| Tandem Clinical Research (Interspond) | Type 2 Diabetes | 1 |
| Tandem Clinical Research - Marrero - Barataria Boulevard | Migraine | 1 |
Active & Upcoming Studies in Marrero (2026)
Recruiting trials in Marrero grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (12 active studies)
- Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer · Phase 3 · National Cancer Institute (NCI)
- Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · Phase 3 · National Cancer Institute (NCI)
Diabetes & metabolic (6 active studies)
Neurology & pain (4 active studies)
- DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea. · Phase 2 · Incannex Healthcare Ltd
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) · Phase 3 · Bristol-Myers Squibb
HIV / STI (1 active study)
Mental health & behavior (1 active study)
- A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder · Phase 3 · Cybin IRL Limited
Common conditions studied in Marrero
- Alzheimer Disease (2 active studies). Alzheimer's research investigates anti-amyloid antibodies, tau-targeted therapies, and lifestyle interventions aimed at slowing cognitive decline.
- Alzheimers Disease (2 active studies). Alzheimer's research investigates anti-amyloid antibodies, tau-targeted therapies, and lifestyle interventions aimed at slowing cognitive decline.
- Crohn's Disease (2 active studies). Recruiting Crohn's Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Eosinophilic Esophagitis (2 active studies). Recruiting Eosinophilic Esophagitis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Liver Fibrosis (2 active studies). Recruiting Liver Fibrosis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Major Depressive Disorder (2 active studies). Major depressive disorder research examines rapid-acting agents, augmentation strategies, and digital therapeutics for treatment-resistant cases.
Leading research sponsors in Marrero
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- National Cancer Institute (NCI)
- Akero Therapeutics, Inc
- Boehringer Ingelheim
Local regulations and guidelines
Clinical trials in Louisiana are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Louisiana research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Marrero. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Marrero
Hipa.ai aggregates every recruiting study in Marrero from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Marrero?
There are approximately 55 recruiting clinical trials in Marrero, Louisiana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Marrero pay participants?
Most recruiting trials in Marrero compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Marrero?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Marrero?
The most common conditions under active study in Marrero include Alzheimer Disease (2), Alzheimers Disease (2), Crohn's Disease (2), Eosinophilic Esophagitis (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Marrero?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Marrero on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Marrero?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Marrero?
Recruiting research sites in Marrero include West Jefferson Medical Center, Tandem Clinical Research, Tandem Clinical Research - Marrero, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Marrero right now?
The largest active categories in Marrero are Cancer & tumors (12), Diabetes & metabolic (6), Neurology & pain (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.